Ruptur Varises Esofagus
Published on September 11, 2026
Risk Factors
Portal hypertension (most commonly from cirrhosis due to alcohol use or chronic hepatitis B/C), large varix size (>5 mm), Child-Pugh class B or C, red wale marks on endoscopy, active alcohol use, prior variceal bleed
Etiology
Sustained elevation of portal venous pressure leading to formation and rupture of dilated esophageal submucosal veins
Presentation
Sudden-onset, painless, large-volume hematemesis; melena; lightheadedness; syncope; may present with hemodynamic instability
Classic Exam
Stigmata of chronic liver disease: spider angiomata, palmar erythema, jaundice, ascites, splenomegaly, caput medusae, gynecomastia, testicular atrophy
Diagnostics
Upper endoscopy (esophagogastroduodenoscopy) revealing dilated submucosal veins with active bleeding, a white nipple sign, or adherent clot; hepatic venous pressure gradient (HVPG)
Management
Volume resuscitation with restrictive transfusion strategy (target hemoglobin ), IV octreotide, prophylactic IV antibiotics, urgent upper endoscopy with endoscopic band ligation within 12 hours
01Pathophysiology
The root cause of esophageal varices is portal hypertension, which in most clinical scenarios arises from hepatic cirrhosis. Chronic liver injury, whether from alcohol, viral hepatitis, or other insults, leads to progressive fibrosis and architectural distortion of the hepatic parenchyma. This fibrosis increases intrahepatic vascular resistance, which raises pressure within the portal venous system. Normal portal pressure is approximately . When the hepatic venous pressure gradient (HVPG) exceeds , varices begin to form. When HVPG reaches , the risk of variceal hemorrhage becomes clinically significant.
As portal pressure rises, blood seeks alternative low-resistance pathways to return to the systemic circulation. These portosystemic collaterals develop at several anatomical sites, but the most clinically dangerous are the submucosal veins of the distal esophagus and gastric fundus. These veins were never designed to handle high-pressure, high-volume flow. They become progressively dilated, tortuous, and thin-walled. The critical concept here is wall tension: according to the Law of Laplace (), as the transmural pressure () increases and the vessel radius () enlarges, wall tension () rises dramatically. Once wall tension exceeds the tensile strength of the vessel wall, rupture occurs.
This is why the vignette patient presents with painless, large-volume hematemesis. The bleeding is painless because the esophageal mucosa overlying the varix erodes passively under pressure rather than through an inflammatory or ulcerative process. The volume of hemorrhage can be profound because these collateral channels carry a substantial fraction of portal blood flow, and the bleeding is arterial-equivalent in pressure. Patients rapidly develop signs of hypovolemic shock: tachycardia, hypotension, pallor, and altered mental status.
The connection between pathophysiology and physical exam findings is direct. Spider angiomata reflect hyperestrogenism due to impaired hepatic estrogen metabolism. Ascites results from portal hypertension combined with decreased albumin synthesis and sodium retention via the renin-angiotensin-aldosterone system. Splenomegaly is caused by congestion from portal venous back-pressure. Jaundice reflects the liver's inability to conjugate and excrete bilirubin. All of these signs point back to the cirrhotic liver that caused the portal hypertension in the first place.
02Classification and Clinical Manifestation
Variceal Size Classification
Small (Grade I)
ENDOSCOPIC APPEARANCE
Minimally elevated veins above the mucosal surface, straighten with insufflation
CLINICAL SIGNIFICANCE
Lower bleeding risk; may be managed with beta-blocker prophylaxis alone
Medium (Grade II)
ENDOSCOPIC APPEARANCE
Tortuous veins occupying less than one-third of the esophageal lumen, do not flatten with insufflation
CLINICAL SIGNIFICANCE
Intermediate risk; prophylaxis indicated
Large (Grade III)
ENDOSCOPIC APPEARANCE
Tortuous veins occupying more than one-third of the lumen, often with red wale marks or cherry-red spots
CLINICAL SIGNIFICANCE
Highest bleeding risk; prophylactic band ligation or beta-blockers strongly recommended
GRADE | ENDOSCOPIC APPEARANCE | CLINICAL SIGNIFICANCE |
|---|---|---|
Small (Grade I) | Minimally elevated veins above the mucosal surface, straighten with insufflation | Lower bleeding risk; may be managed with beta-blocker prophylaxis alone |
Medium (Grade II) | Tortuous veins occupying less than one-third of the esophageal lumen, do not flatten with insufflation | Intermediate risk; prophylaxis indicated |
Large (Grade III) | Tortuous veins occupying more than one-third of the lumen, often with red wale marks or cherry-red spots | Highest bleeding risk; prophylactic band ligation or beta-blockers strongly recommended |
High-Risk Stigmata on Endoscopy
FINDING | SIGNIFICANCE |
|---|---|
Red wale marks | Longitudinal red streaks on the varix surface indicating thin, stretched epithelium; strong predictor of imminent rupture |
Cherry-red spots | Discrete red dots on the varix; indicate focal areas of extreme wall thinning |
White nipple sign | Platelet-fibrin plug on varix surface; indicates recent bleeding |
Hematocystic spots | Raised blood-filled blisters on the varix; indicate very high rupture risk |
Child-Pugh Classification (Severity of Underlying Cirrhosis)
Bilirubin (mg/dL)
1 POINT
<2
2 POINTS
2-3
3 POINTS
>3
Albumin (g/dL)
1 POINT
>3.5
2 POINTS
2.8-3.5
3 POINTS
<2.8
INR
1 POINT
<1.7
2 POINTS
1.7-2.3
3 POINTS
>2.3
Ascites
1 POINT
None
2 POINTS
Mild (controlled)
3 POINTS
Moderate to severe (refractory)
Encephalopathy
1 POINT
None
2 POINTS
Grade I-II
3 POINTS
Grade III-IV
PARAMETER | 1 POINT | 2 POINTS | 3 POINTS |
|---|---|---|---|
Bilirubin (mg/dL) | <2 | 2-3 | >3 |
Albumin (g/dL) | >3.5 | 2.8-3.5 | <2.8 |
INR | <1.7 | 1.7-2.3 | >2.3 |
Ascites | None | Mild (controlled) | Moderate to severe (refractory) |
Encephalopathy | None | Grade I-II | Grade III-IV |
A
SCORE
5-6
RELEVANCE TO VARICEAL BLEEDING
Lower risk of variceal formation and bleeding
B
SCORE
7-9
RELEVANCE TO VARICEAL BLEEDING
Moderate risk; screening endoscopy recommended
C
SCORE
10-15
RELEVANCE TO VARICEAL BLEEDING
Highest risk of variceal bleeding and mortality; carries poorest prognosis after hemorrhage
CLASS | SCORE | RELEVANCE TO VARICEAL BLEEDING |
|---|---|---|
A | 5-6 | Lower risk of variceal formation and bleeding |
B | 7-9 | Moderate risk; screening endoscopy recommended |
C | 10-15 | Highest risk of variceal bleeding and mortality; carries poorest prognosis after hemorrhage |
03Diagnostic Workup
CBC
PURPOSE
Assess hemoglobin, hematocrit, platelet count (thrombocytopenia common in hypersplenism)
TIMING
Immediately on presentation
BMP/CMP
PURPOSE
Evaluate renal function, electrolytes, hepatic synthetic function
TIMING
Immediately on presentation
Coagulation studies (PT/INR)
PURPOSE
Assess coagulopathy related to hepatic dysfunction
TIMING
Immediately on presentation
Type and crossmatch
PURPOSE
Prepare for transfusion
TIMING
Immediately on presentation
Liver function tests
PURPOSE
Confirm underlying liver disease and severity
TIMING
On presentation
Blood lactate
PURPOSE
Gauge severity of tissue hypoperfusion
TIMING
On presentation
Upper endoscopy (EGD)
PURPOSE
Best initial test AND gold standard: directly visualizes the bleeding source and allows therapeutic intervention
TIMING
Within 12 hours of presentation (after initial resuscitation)
HVPG measurement
PURPOSE
Confirms portal hypertension; correlates with bleeding risk
TIMING
Not typically done acutely; used in risk stratification
CT abdomen with contrast
PURPOSE
Identifies cirrhotic liver, ascites, splenomegaly, collateral vessels; useful when diagnosis is unclear
TIMING
When the etiology of upper GI bleeding is uncertain
TEST | PURPOSE | TIMING |
|---|---|---|
CBC | Assess hemoglobin, hematocrit, platelet count (thrombocytopenia common in hypersplenism) | Immediately on presentation |
BMP/CMP | Evaluate renal function, electrolytes, hepatic synthetic function | Immediately on presentation |
Coagulation studies (PT/INR) | Assess coagulopathy related to hepatic dysfunction | Immediately on presentation |
Type and crossmatch | Prepare for transfusion | Immediately on presentation |
Liver function tests | Confirm underlying liver disease and severity | On presentation |
Blood lactate | Gauge severity of tissue hypoperfusion | On presentation |
Upper endoscopy (EGD) | Best initial test AND gold standard: directly visualizes the bleeding source and allows therapeutic intervention | Within 12 hours of presentation (after initial resuscitation) |
HVPG measurement | Confirms portal hypertension; correlates with bleeding risk | Not typically done acutely; used in risk stratification |
CT abdomen with contrast | Identifies cirrhotic liver, ascites, splenomegaly, collateral vessels; useful when diagnosis is unclear | When the etiology of upper GI bleeding is uncertain |
Upper endoscopy is both the best initial diagnostic test and the most accurate confirmatory test. This is a critical point for exam purposes. Unlike many diseases where the screening test and gold standard differ, variceal hemorrhage is a situation where a single procedure serves as both the diagnostic and the therapeutic intervention.
The workup begins at the bedside. When a patient with known or suspected liver disease presents with hematemesis, you should immediately draw a complete blood count to quantify blood loss (keeping in mind that hemoglobin may not yet reflect the full severity of acute hemorrhage due to hemoconcentration), coagulation studies (PT/INR will often be elevated due to impaired hepatic synthesis of clotting factors), and a comprehensive metabolic panel to assess renal function and hepatic markers. A type and crossmatch is ordered early because transfusion is almost always necessary.
The pivotal step is urgent upper endoscopy, which should be performed within 12 hours of presentation, ideally after the patient has been hemodynamically stabilized. Endoscopy will directly visualize the esophageal varices and identify whether they are the source of bleeding. It also distinguishes variceal bleeding from other causes of upper GI hemorrhage (peptic ulcer, Mallory-Weiss tear, gastric malignancy). Once varices are identified as the source, endoscopic band ligation is performed during the same procedure, making it simultaneously diagnostic and therapeutic.
An important nuance: do not delay endoscopy for "perfect" resuscitation. Prolonged aggressive fluid resuscitation can paradoxically worsen portal hypertension and rebleeding. The goal is hemodynamic stability sufficient for safe sedation, not normalization of all parameters.
04Management and Treatment
Acute resuscitation
INTERVENTION
IV crystalloid and packed red blood cells
DETAILS
Restrictive strategy: transfuse to target hemoglobin ; over-transfusion worsens portal pressure
Vasoactive therapy
INTERVENTION
Octreotide
DETAILS
50 mcg IV bolus, then 50 mcg/hr continuous infusion for 3-5 days
Vasoactive therapy (alternative)
INTERVENTION
Terlipressin (where available)
DETAILS
2 mg IV every 4 hours for 48 hours, then 1 mg IV every 4 hours for up to 5 days
Antibiotic prophylaxis
INTERVENTION
Ceftriaxone
DETAILS
1 g IV once daily for 7 days; reduces infection-related mortality
Definitive hemostasis
INTERVENTION
Endoscopic band ligation (EBL)
DETAILS
Performed during urgent EGD within 12 hours; preferred over sclerotherapy
Rescue therapy (refractory bleeding)
INTERVENTION
Balloon tamponade (Sengstaken-Blakemore or Minnesota tube)
DETAILS
Temporary bridge (maximum 24 hours) to definitive therapy; high complication rate
Rescue therapy (refractory bleeding)
INTERVENTION
Transjugular intrahepatic portosystemic shunt (TIPS)
DETAILS
Creates a low-resistance channel between the portal and hepatic veins, reducing portal pressure; used when EBL fails
Secondary prophylaxis
INTERVENTION
Non-selective beta-blocker + repeat band ligation
DETAILS
Nadolol 40 mg daily or propranolol 20 mg twice daily (titrate to resting heart rate of ); band ligation repeated every 2-4 weeks until variceal obliteration
Primary prophylaxis (no prior bleed)
INTERVENTION
Non-selective beta-blocker OR band ligation
DETAILS
For patients with medium or large varices who have never bled
PHASE | INTERVENTION | DETAILS |
|---|---|---|
Acute resuscitation | IV crystalloid and packed red blood cells | Restrictive strategy: transfuse to target hemoglobin ; over-transfusion worsens portal pressure |
Vasoactive therapy | Octreotide | 50 mcg IV bolus, then 50 mcg/hr continuous infusion for 3-5 days |
Vasoactive therapy (alternative) | Terlipressin (where available) | 2 mg IV every 4 hours for 48 hours, then 1 mg IV every 4 hours for up to 5 days |
Antibiotic prophylaxis | Ceftriaxone | 1 g IV once daily for 7 days; reduces infection-related mortality |
Definitive hemostasis | Endoscopic band ligation (EBL) | Performed during urgent EGD within 12 hours; preferred over sclerotherapy |
Rescue therapy (refractory bleeding) | Balloon tamponade (Sengstaken-Blakemore or Minnesota tube) | Temporary bridge (maximum 24 hours) to definitive therapy; high complication rate |
Rescue therapy (refractory bleeding) | Transjugular intrahepatic portosystemic shunt (TIPS) | Creates a low-resistance channel between the portal and hepatic veins, reducing portal pressure; used when EBL fails |
Secondary prophylaxis | Non-selective beta-blocker + repeat band ligation | Nadolol 40 mg daily or propranolol 20 mg twice daily (titrate to resting heart rate of ); band ligation repeated every 2-4 weeks until variceal obliteration |
Primary prophylaxis (no prior bleed) | Non-selective beta-blocker OR band ligation | For patients with medium or large varices who have never bled |
Step 1: Acute Resuscitation. The immediate priority is hemodynamic stabilization. Establish two large-bore IV lines (16-gauge or larger). Begin volume resuscitation with isotonic crystalloid. Transfuse packed red blood cells using a restrictive transfusion strategy with a target hemoglobin of . This threshold is deliberately conservative because over-transfusion increases portal pressure and raises the risk of rebleeding. This is one of the most commonly tested concepts. Fresh frozen plasma and platelets should be given for clinically significant coagulopathy, but routine correction of INR in a cirrhotic patient is not standard practice because the INR does not accurately reflect bleeding risk in cirrhosis.
Step 2: Pharmacologic Therapy (Start Before Endoscopy). Begin octreotide as soon as variceal hemorrhage is suspected, even before endoscopy. Octreotide causes splanchnic vasoconstriction, reducing portal blood flow and portal pressure. The dose is a 50 mcg IV bolus followed by a 50 mcg/hr continuous infusion for 3 to 5 days. Where available, terlipressin (a vasopressin analogue) is an alternative, dosed at 2 mg IV every 4 hours initially, then reduced to 1 mg IV every 4 hours after bleeding is controlled, continued for up to 5 days.
Step 3: Prophylactic Antibiotics. This is a frequently tested and commonly missed step. Patients with cirrhosis who present with upper GI bleeding have a very high rate of bacterial infections (spontaneous bacterial peritonitis, urinary tract infections, pneumonia), and these infections worsen outcomes. Ceftriaxone 1 g IV once daily for 7 days is the recommended regimen. Antibiotic prophylaxis has been shown to reduce mortality, not just infection rates. An alternative in patients without advanced liver disease is oral norfloxacin 400 mg twice daily.
Step 4: Urgent Endoscopy with Band Ligation. Perform upper endoscopy within 12 hours. Administer IV erythromycin (250 mg) approximately 30-120 minutes before endoscopy as a prokinetic to clear blood from the stomach and improve visualization. Endoscopic band ligation (EBL) is the procedure of choice. Bands are placed on the varices starting at the gastroesophageal junction and working proximally. EBL is preferred over endoscopic sclerotherapy because it has fewer complications (fewer strictures, fewer ulcerations, lower rebleeding rates).
Step 5: Rescue Therapy for Refractory Bleeding. If bleeding persists despite two sessions of endoscopic therapy plus vasoactive drugs, the next step is TIPS (transjugular intrahepatic portosystemic shunt). TIPS creates a shunt between the portal vein and the hepatic vein within the liver parenchyma, directly lowering portal pressure. The primary complication of TIPS is hepatic encephalopathy, because portal blood now bypasses the liver. Balloon tamponade with a Sengstaken-Blakemore tube or Minnesota tube is used only as a temporary bridge (less than 24 hours) to TIPS or repeat endoscopy, due to the risk of esophageal rupture and aspiration.
Step 6: Long-Term Secondary Prophylaxis. After the acute episode resolves, patients require combination therapy to prevent rebleeding: a non-selective beta-blocker (nadolol or propranolol, titrated to a resting heart rate of ) combined with serial endoscopic band ligation sessions every 2 to 4 weeks until the varices are obliterated. Non-selective beta-blockers work by reducing cardiac output (beta-1 blockade) and causing splanchnic vasoconstriction (beta-2 blockade), both of which lower portal pressure. Carvedilol is an emerging option with additional alpha-1 blocking properties that further reduce portal resistance.
Contraindications to note: Non-selective beta-blockers are contraindicated in patients with refractory ascites, spontaneous bacterial peritonitis, or a systolic blood pressure below 90 mmHg, as they can worsen hemodynamics in these decompensated patients.
05Differential Diagnosis and Distractors
Mallory-Weiss tear
WHY IT IS SIMILAR
Also presents with hematemesis in a patient who may drink alcohol
KEY DISCRIMINATOR
Preceded by forceful retching or vomiting; bleeding is typically self-limited; tear is at the gastroesophageal junction, not from a varix; no stigmata of chronic liver disease required
Peptic ulcer disease (bleeding gastric or duodenal ulcer)
WHY IT IS SIMILAR
Common cause of upper GI bleeding; patient may have epigastric pain
KEY DISCRIMINATOR
History of NSAID use or H. pylori infection; epigastric pain or burning; endoscopy shows a clean-based or cratered ulcer with a visible vessel, not a variceal column
Gastric variceal bleeding
WHY IT IS SIMILAR
Also caused by portal hypertension; occurs in cirrhotics
KEY DISCRIMINATOR
Varices are located in the gastric fundus (isolated gastric varices raise suspicion for splenic vein thrombosis); treated with cyanoacrylate glue injection rather than band ligation
Boerhaave syndrome (esophageal perforation)
WHY IT IS SIMILAR
Presents after vomiting with acute distress
KEY DISCRIMINATOR
Severe chest or epigastric pain, subcutaneous emphysema, Hamman crunch on auscultation; imaging shows pneumomediastinum; this is a full-thickness perforation, not a vascular rupture
Aortoenteric fistula
WHY IT IS SIMILAR
Catastrophic upper GI bleeding
KEY DISCRIMINATOR
History of prior aortic graft surgery; "herald bleed" (small initial bleed followed by exsanguinating hemorrhage); CT angiography is diagnostic
Dieulafoy lesion
WHY IT IS SIMILAR
Presents with painless, recurrent upper GI bleeding
KEY DISCRIMINATOR
No associated cirrhosis or portal hypertension; endoscopy reveals an isolated, aberrant submucosal arteriole protruding through a tiny mucosal defect, usually in the gastric body
Hemobilia
WHY IT IS SIMILAR
Upper GI bleeding in a patient with liver disease
KEY DISCRIMINATOR
Preceded by hepatobiliary instrumentation (liver biopsy, ERCP); classic Quincke triad of jaundice, right upper quadrant pain, and upper GI bleeding
DIFFERENTIAL | WHY IT IS SIMILAR | KEY DISCRIMINATOR |
|---|---|---|
Mallory-Weiss tear | Also presents with hematemesis in a patient who may drink alcohol | Preceded by forceful retching or vomiting; bleeding is typically self-limited; tear is at the gastroesophageal junction, not from a varix; no stigmata of chronic liver disease required |
Peptic ulcer disease (bleeding gastric or duodenal ulcer) | Common cause of upper GI bleeding; patient may have epigastric pain | History of NSAID use or H. pylori infection; epigastric pain or burning; endoscopy shows a clean-based or cratered ulcer with a visible vessel, not a variceal column |
Gastric variceal bleeding | Also caused by portal hypertension; occurs in cirrhotics | Varices are located in the gastric fundus (isolated gastric varices raise suspicion for splenic vein thrombosis); treated with cyanoacrylate glue injection rather than band ligation |
Boerhaave syndrome (esophageal perforation) | Presents after vomiting with acute distress | Severe chest or epigastric pain, subcutaneous emphysema, Hamman crunch on auscultation; imaging shows pneumomediastinum; this is a full-thickness perforation, not a vascular rupture |
Aortoenteric fistula | Catastrophic upper GI bleeding | History of prior aortic graft surgery; "herald bleed" (small initial bleed followed by exsanguinating hemorrhage); CT angiography is diagnostic |
Dieulafoy lesion | Presents with painless, recurrent upper GI bleeding | No associated cirrhosis or portal hypertension; endoscopy reveals an isolated, aberrant submucosal arteriole protruding through a tiny mucosal defect, usually in the gastric body |
Hemobilia | Upper GI bleeding in a patient with liver disease | Preceded by hepatobiliary instrumentation (liver biopsy, ERCP); classic Quincke triad of jaundice, right upper quadrant pain, and upper GI bleeding |
06Traps and High-Yield Pearls
The single most common trap with variceal hemorrhage questions is forgetting the antibiotics. Students correctly identify the need for resuscitation, octreotide, and urgent endoscopy, but omit prophylactic ceftriaxone. On the exam, when the question asks for the "next best step" in a patient who has already been started on octreotide and is awaiting endoscopy, the answer is often the antibiotic, not another intervention.
A second frequent error is over-transfusion. A vignette may describe a hemoglobin of 6 g/dL and offer answer choices that include "transfuse to hemoglobin of 10 g/dL." This is a deliberate distractor. The correct target is . Transfusing beyond this threshold raises portal venous pressure and increases the likelihood of rebleeding. This restrictive strategy is counterintuitive for students trained to "correct the number," and test-writers exploit that instinct.
A third pitfall involves confusing primary versus secondary prophylaxis. A patient with known cirrhosis who has varices on screening endoscopy but has never bled is managed with either a non-selective beta-blocker or band ligation (not both). A patient who has already had a variceal bleed requires both a non-selective beta-blocker and serial band ligation. Mixing up these regimens is a common source of wrong answers.
Watch for vignettes that present a patient with portal hypertension and upper GI bleeding but try to trick you into selecting a peptic ulcer diagnosis. The giveaway for varices is the constellation of painless hematemesis combined with physical exam findings of chronic liver disease (ascites, splenomegaly, spider angiomata, jaundice). If the stem mentions epigastric pain, NSAID use, or H. pylori, it is steering you toward peptic ulcer disease instead.
Finally, remember the sequencing of interventions. Pharmacotherapy (octreotide) and antibiotics are started before endoscopy. Band ligation is preferred over sclerotherapy. TIPS is used only after endoscopic therapy has failed. Balloon tamponade is a bridge, not a definitive treatment. The exam tests whether you understand this hierarchy, not just whether you can name the correct treatments.